Status:
UNKNOWN
Urine Exosomes to Identify Biomarkers for LN
Lead Sponsor:
RenJi Hospital
Conditions:
Lupus Nephritis
Eligibility:
All Genders
Brief Summary
Urine exosomes will be extracted from patients with lupus nephritis, healthy controls, and patients with systemic lupus erythematosus without lupus nephritis. Transcriptome and/or metabonomics sequenc...
Detailed Description
Lupus nephritis is one of the most common complications of SLE, and its severity is closely related to the prognosis of SLE. The gold standard for diagnosing lupus nephritis depends on the pathologica...
Eligibility Criteria
Inclusion
- No history of chronic or serious diseases such as cardiovascular disease, liver disease, kidney disease, respiratory disease, blood disease, lymphatic disease, endocrine disease, immune disease, mental disease, neuromuscular disease, gastrointestinal system disease, etc.
- General health condition is good;
- Vital signs examination, physical examination, clinical laboratory examination (blood routine, urine routine, blood biochemical examination, coagulation function examination), electrocardiogram, and the results show normal or abnormal without clinical significance
Exclusion
- Other rheumatic immune disease;
- Abnormal liver and kidney function;
- Acute and chronic infectious diseases.
Key Trial Info
Start Date :
August 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04894695
Start Date
August 2 2020
End Date
August 31 2021
Last Update
August 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China, 021